# US 2026/0275394 A1 · Improved biotechnological process to produce guanidinoacetic acid (gaa) by targeted introduction or by increasing the activity of a transmembrane exporter protein

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0275394 A1
- Document ID: US20260275394A1
- Status: Published application
- Kind: A1
- Application number: 19/124,954
- Filed: 2023-10-24
- Published: 2026-09-17
- Earliest claimed: 2022-11-03
- Assignees: Evonik Operations GmbH
- Applicants: Evonik Operations GmbH
- Inventors: Kay Marin; Frank Schneider
- Web page: https://patentgrep.com/patent/US20260275394A1

## CPC

- C12N 9/1003: {transferring one-carbon groups (2.1)}
- C12P 13/005: {Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids}
- C07K 14/34: from Corynebacterium (G)
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12P 13/00: Preparation of nitrogen-containing organic compounds
- C12P 13/04: Alpha- or beta- amino acids {(other amino acids C12P13/005)}
- C12Y 201/01002: Guanidinoacetate N-methyltransferase (2.1.1.2)
- C12Y 201/04001: Glycine amidinotransferase (2.1.4.1)
- C12N 2830/34: being a transcription initiation element
- C12R 2001/01: Bacteria or Actinomycetales {; using bacteria or Actinomycetales}
- C12R 2001/15: Corynebacterium
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12Y: ENZYMES
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

A microorganism has at least one gene coding for a protein having the function of a L-arginine:glycine amidinotransferase and having an increased activity of a transmembrane exporter protein. A method for the fermentative production of guanidino acetic acid (GAA) as well as a method for the fermentative production of creatine employ such microorganism.

## Claims

### Claim 1

A microorganism, comprising;
at least one heterologous or synthetic gene coding for a protein having a function of an L-arginine:glycine amidinotransferase and having an overexpressed gene coding for a transmembrane exporter protein, wherein the transmembrane exporter protein is selected from the group consisting of proteins of the Drug/Metabolite Transporter (DMT) superfamily (TC 2.A.7), from proteins of the 10 TMS Drug/Metabolite Exporter (DME) Family (TC 2.A.7.3), from proteins of the Threonine/Serine Exporter (ThrE) Family (TC 2.A.79), and from proteins of the Resistance to Homoserine/Threonine (RhtB) Family (TC 2.A.76).

### Claim 2 (depends on 1)

The microorganism of claim 1, wherein the transmembrane exporter protein has an identity of at least 20% to a protein comprising an amino acid sequence according to SEQ ID NO:6 or to a protein comprising an amino acid sequence according to SEQ ID NO: 10 or to a protein comprising an amino acid sequence according to SEQ ID NO: 14.

### Claim 3 (depends on 1)

The microorganism of claim 1, wherein the transmembrane exporter protein has an identity of at least 70% to a protein comprising an amino acid sequence according to SEQ ID NO:6 or to a protein comprising an amino acid sequence according to SEQ ID NO:10 or to a protein comprising an amino acid sequence according to SEQ ID NO: 14.

### Claim 4 (depends on 2)

The microorganism of claim 2, wherein the transmembrane exporter protein is encoded by an open reading frame of gene NCgl0580 of Corynebacterium glutamicum according to Seq ID NO:5.

### Claim 5 (depends on 2)

The microorganism of claim 2, wherein the transmembrane exporter protein is encoded by an open reading frame of gene NCgl2533 of Corynebacterium glutamicum according to Seq ID NO:9.

### Claim 6 (depends on 2)

The microorganism of claim 2, wherein the transmembrane exporter protein is encoded by an open reading frame of gene NCgl2566 of Corynebacterium glutamicum according to SEQ ID NO:13.

### Claim 7 (depends on 1)

The microorganism of claim 1, wherein an overexpression of agene coding for a transmembrane exporter protein is achieved by increasing a copy number of a gene and/or by functionally linking the gene with a strong promoter and/or by enhancing a ribosomal binding site and/or by codon usage optimization of a start codon or of a whole gene.

### Claim 8 (depends on 1)

The microorganism of claim 1, wherein the microorganism has an increased ability to produce L-arginine from L-orithine compared with an ability of a wildtype microorganism.

### Claim 9 (depends on 8)

The microorganism of claim 8, wherein an expression of an argR gene coding for an arginine responsive repressor protein ArgR is attenuated compared to an expression of an argR gene in the wildtype microorganism or wherein the argR gene is inactivated or deleted.

### Claim 10 (depends on 1)

A method for a fermentative production of guanidino acetic acid (GAA), the method comprising:
cultivating the microorganism as defined in claim 1 in a medium, and
accumulating GAA in the medium to form a GAA containing fermentation broth.

### Claim 11 (depends on 10)

The method of claim 10, further comprising:
isolating GAA from the GAA containing fermentation broth.

### Claim 12 (depends on 1)

A The microorganism as claimed in claim 1, further comprising:
a gene coding for an enzyme having an activity of a guanidinoacetate N-methyltransferase.

### Claim 13 (depends on 12)

The microorganism of claim 12, wherein the gene coding for an enzyme having the activity of a guanidinoacetate N-methyltransferase is overexpressed.

### Claim 14 (depends on 12)

A method for a fermentative production of creatine, the method comprising:
cultivating the microorganism as defined in claim 12, and
accumulating creatine in the medium to form a creatine containing fermentation broth.

### Claim 15 (depends on 14)

The method of claim 14, further comprising:
isolating creatine from the creatine containing fermentation broth.
